Patent US4204989A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4204989A Expired / Lapsed US ⏱️ 0.0 years remaining

Isolation of hepatitis B e antigen

Assignee: Merck and Co Inc
•
Filing: 1978-12-13
•
Granted: 1980-05-27
•
Expires: 1998-12-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Hepatitis B e antigen or hepatitis B e antibody are separated from human biological fluid by centrifugation in a density gradient and isolated in the 1.04-1.15 g/cc density region.

Inventors

  • 👤 William J. McAleer
  • 👤 Edward H. Wasmuth

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 22:36
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/576; G01N33/5761; C12; C12N; C12N2730/00; C12N2730/00011; C12N2730/10011; C12N2730/10111; C12N2730/10122; Y; Y10; Y10S; Y10S530/00; Y10S530/806; Y10S530/827; Y10S530/829; Y10S530/83

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 88 words
A method for isolating hepatitis B e antigen or hepatitis B e antibody which comprises isopycnically banding human biological fluid which contains hepatitis B surface antigen, recovering a fraction having a density range of from about 1.04 to about 1.15 g/cc, and and isolating HB e Ab if the plasma has an HB s Ag titer measured by complement fixation of at least about 256, or isolating HB e Ag if the plasma has an HB s Ag titer measured by complement fixation of less than about 128.
Claim 2
Independent Claim 88 words
A method for isolating hepatitis B e antigen or hepatitis B e antibody which comprises isopycnically banding human biological fluid which contains hepatitis B surface antigen, recovering a fraction having a density range of from about 1.04 to about 1.15 g/cc, and and isolating HB e Ab if the plasma has an HB s Ag titer measured by complement fixation of at least about 256, or isolating HB e Ag if the plasma has an HB s Ag titer measured by complement fixation of less than about 128.
Claim 3
Dependent Claim 14 words
A method according to claim 1 wherein the human biological fluid is clarified plasma.
Claim 4
Dependent Claim 18 words
A method according to claim 1 wherein the isopycnic banding is effected in an aqueous solution of NaBr.
Claim 5
Independent Claim 105 words
A method for isolating hepatitis B e antigen which comprises isopycnically banding human biological fluid which has a hepatitis B surface antigen titer measured by complement fixation of at least about 256, recovering a first fraction having a density range of from about 1.04 to about 1.15 g/cc, recovering a second fraction in the density range of from about 1.17 to about 1.22 g/cc, dialyzing and concentrating the second fraction, subjecting the concentrated second fraction to rate zonal banding and recovering a third fraction having a density range of from about 1.04 to about 1.15 g/cc, and dialyzing and concentrating the first and third fractions.
Claim 6
Independent Claim 105 words
A method for isolating hepatitis B e antigen which comprises isopycnically banding human biological fluid which has a hepatitis B surface antigen titer measured by complement fixation of at least about 256, recovering a first fraction having a density range of from about 1.04 to about 1.15 g/cc, recovering a second fraction in the density range of from about 1.17 to about 1.22 g/cc, dialyzing and concentrating the second fraction, subjecting the concentrated second fraction to rate zonal banding and recovering a third fraction having a density range of from about 1.04 to about 1.15 g/cc, and dialyzing and concentrating the first and third fractions.
Claim 7
Dependent Claim 14 words
A method according to claim 4 wherein the human biological fluid is clarified plasma.
Claim 8
Independent Claim 109 words
A method for isolating hepatitis B e antibody which comprises isopycnically banding human biological fluid which has a hepatitis B surface antigen titer as measured by complement fixation of less than about 128, recovering a first fraction having a density range of from about 1.04 to about 1.15 g/cc, recovering a second fraction in the density range of from about 1.17 to about 1.22 g/cc, dialyzing and concentrating the second fraction, subjecting the concentrated second fraction to rate zonal banding and recovering a third fraction having a density range of from about 1.04 to about 1.04 to about 1.15 g/cc, and dialyzing and concentrating the first and third fractions.
Claim 9
Independent Claim 109 words
A method for isolating hepatitis B e antibody which comprises isopycnically banding human biological fluid which has a hepatitis B surface antigen titer as measured by complement fixation of less than about 128, recovering a first fraction having a density range of from about 1.04 to about 1.15 g/cc, recovering a second fraction in the density range of from about 1.17 to about 1.22 g/cc, dialyzing and concentrating the second fraction, subjecting the concentrated second fraction to rate zonal banding and recovering a third fraction having a density range of from about 1.04 to about 1.04 to about 1.15 g/cc, and dialyzing and concentrating the first and third fractions.
Claim 10
Dependent Claim 14 words
A method according to claim 6 wherein the human biological fluid is clarified plasma.
Claim 11
Dependent Claim 14 words
A method according to claim 3 wherein the aqueous solution is a density gradient.
Claim 12
Dependent Claim 18 words
A method according to claim 4 wherein the isopycnic banding is effected in an aqueous solution of NaBr.
Claim 13
Dependent Claim 18 words
A method according to claim 6 wherein the isopycnic banding is effected in an aqueous solution of NaBr.

References Cited (Backward Citations)

US3636191A Cited
US3887697A Cited
US3838144A Cited
US3994870A Cited
US3992517A Cited
US4024243A Cited
US4087519A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-05-27 1983-11-26 1984-05-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-05-27 1987-11-26 1988-05-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-05-27 1991-11-26 1992-05-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag